An observational study in Rheumatoid Arthritis and Ankylosing Spondylitis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Completed at 1 site in United States. Open to participants aged 20 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Arthritis, Rheumatoid by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — 1 open to participants now, 1 under way, none of them phase 3. Arthritis, Rheumatoid · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
Among the 19 studies in Arthritis, Rheumatoid by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), this one has the largest enrollment of the 11 observational ones that give a count, is the only one that started in 2014, is one of 12 observational ones, and was the 18th registered.
3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.
Browse Arthritis, Rheumatoid studies →1 of the 19 studies in Arthritis, Rheumatoid by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is open now, in 1 country. Recruiting first, the newest first:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Sites in United States
Ages 9–85 · Healthy volunteers
By country, each count listing its studies:
Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.
This study: 20 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 1991; this study’s year is marked. 1 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 521,292 is above the median of 176 across 1,017 observational studies indexed under Arthritis, Rheumatoid.
Median enrollment 48 across the 7 interventional studies, 250 across the 11 observational. Of the 18 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is the lead sponsor of 100 studies on the registry; 12 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 19 studies in Arthritis, Rheumatoid by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background:
- Orthopedic procedures are common in the United States. These include joint replacement and spine surgeries. Researchers want to study data about these procedures over time. They want to see if treatment has gotten better. They also want to find ways to change the care that people get before and after they have these procedures. These changes may lower the risk of problems people can have during and after treatment. They may also improve people s results.
Objectives:
- To study a series of questions about surgery, medicine, treatments, and outcomes for orthopedic procedures.
Eligibility:
- Data from the U.S. Centers for Medicare and Medicaid Services from 1999 to 2015.
Design:
Major orthopedic procedures, including total joint replacement and spine surgeries, are among the most common procedures in the population. Learning about how often these surgeries are performed can give indications of whether the treatment of arthritis and other musculoskeletal conditions has been improving over time. Learning about the complications associated with these surgeries can give indications about ways to alter the care of patients before and after surgeries that may decrease the risk of complications and improve patient outcomes. We will analyze Medicare and Medicaid data from 1999 to 2015 to examine a series of questions, including whether the use of joint replacement surgery has changed over time among patients with rheumatoid arthritis and ankylosing spondylitis, to see if rheumatoid arthritis medications are associated with some types of surgical complications, to see if anticoagulation medication after joint replacement is associated with the risk of complications, to see if regional differences in surgery rates can be explained by differences in patient characteristics, and to determine the surgical treatment for hip fractures that is associated with the fewest long-term complications. From the Framingham Heart Study Cohort, we will study the changes in the incidence of hip fractures and the risk factors for osteoporosis over time.
Medicare (1999 to 2015) and Medicaid (1999 to 2015) beneficiaries
Medicare beneficiaries will be excluded (or censored) if they do not have both Part A and Part B coverage, or enrolled in Medicare Advantage plans (Part C), as detailed claims for these beneficiaries are not available. We will also exclude dual-eligible (Medicare and Medicaid recipients) as these subjects have distinct clinical conditions (e.g. blindness) that distinguishes them from most Medicare beneficiaries. There will be no exclusions based on gender, race, ethnicity, or cognitive impairment.
arthritis may be either rheumatoid, osteoarthritis, or ankylosing spondylitis
in some analyses, the comparison is by arthritis status. in other analyses, it is within arthritis status by clinically relevant subgroups.
Complications
Complications
Time frame: 30 days
Plan to share: Undecided — undecided yet
No publications or documents are linked to this record.
Ran from Oct 2014 to primary completion in Nov 2026, 144 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion May 2029 → Nov 2026 and completion May 2029 → Nov 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) →